BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3304 related articles for article (PubMed ID: 21547096)

  • 1. Dr. Frank caldwell garland, june 20, 1950-august 17, 2010.
    Grant WB; Gorham ED
    Dermatoendocrinol; 2010 Apr; 2(2):46-9. PubMed ID: 21547096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ecological study of cancer mortality rates in the United States with respect to solar ultraviolet-B doses, smoking, alcohol consumption and urban/rural residence.
    Grant WB
    Dermatoendocrinol; 2010 Apr; 2(2):68-76. PubMed ID: 21547102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality.
    Grant WB
    Dermatoendocrinol; 2009 Jan; 1(1):17-24. PubMed ID: 20046584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Incidence Rates in the US in 2016-2020 with Respect to Solar UVB Doses, Diabetes and Obesity Prevalence, Lung Cancer Incidence Rates, and Alcohol Consumption: An Ecological Study.
    Grant WB
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In defense of the sun: An estimate of changes in mortality rates in the United States if mean serum 25-hydroxyvitamin D levels were raised to 45 ng/mL by solar ultraviolet-B irradiance.
    Grant WB
    Dermatoendocrinol; 2009 Jul; 1(4):207-14. PubMed ID: 20592792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ecological study of cancer incidence and mortality rates in France with respect to latitude, an index for vitamin D production.
    Grant WB
    Dermatoendocrinol; 2010 Apr; 2(2):62-7. PubMed ID: 21547101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines.
    Grant WB
    Dermatoendocrinol; 2011 Jul; 3(3):199-204. PubMed ID: 22110780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation.
    Grant WB
    Dermatoendocrinol; 2009 Nov; 1(6):289-93. PubMed ID: 21572873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical review of Vitamin D and Cancer: A report of the IARC Working Group.
    Grant WB
    Dermatoendocrinol; 2009 Jan; 1(1):25-33. PubMed ID: 20046585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.
    Grant WB
    Dermatoendocrinol; 2016; 8(1):e1137400. PubMed ID: 27195055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Garland Allen and Marxism: An Appreciation.
    Kleinman K
    J Hist Biol; 2023 Aug; 56(2):227-238. PubMed ID: 37594618
    [No Abstract]   [Full Text] [Related]  

  • 12. A carbon nanotube-polymer composite for T-cell therapy.
    Fadel TR; Sharp FA; Vudattu N; Ragheb R; Garyu J; Kim D; Hong E; Li N; Haller GL; Pfefferle LD; Justesen S; Herold KC; Fahmy TM
    Nat Nanotechnol; 2014 Aug; 9(8):639-47. PubMed ID: 25086604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC; Hirte HW; Singh G
    Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent melanoma of the leg and polypoid lesions of the gallbladder--a management dilemma.
    Gould SW; Banwell PE; Rosin RD
    Eur J Surg Oncol; 1997 Aug; 23(4):368-9. PubMed ID: 9315071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of Cloudman mouse melanoma cells after irradiation by solar wavelengths of light.
    Cieszka K; Hill HZ; Xin P; Azure M; Hill GJ; Meyenhofer MF; Boissy RE; Mitchell DL
    Pigment Cell Res; 1997 Aug; 10(4):193-200. PubMed ID: 9263325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of dacarbazine, cisplatin, interferon-alpha and high-dose interleukin-2 in 'poor-risk' metastatic melanoma.
    Proebstle TM; Scheibenbogen C; Sterry W; Keilholz U
    Eur J Cancer; 1996 Aug; 32A(9):1530-3. PubMed ID: 8911113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro.
    Price EA; Coombe DR; Murray JC
    Int J Cancer; 1996 Feb; 65(4):513-8. PubMed ID: 8621236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of extracellular matrix on two cell lines established from Mongolian Gerbil's (Meriones unguiculatus) malignant melanoma.
    Hashimoto O; Ogawa K; Kurohmaru M; Hayashi Y
    J Vet Med Sci; 1995 Aug; 57(4):635-40. PubMed ID: 8519890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Psoriasis Disability Index--further analyses.
    Kent G; al-Abadie M
    Clin Exp Dermatol; 1993 Sep; 18(5):414-6. PubMed ID: 8252760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer simulations of histologic patterns in melanoma using a cellular automaton provide correlations with prognosis.
    Smolle J; Hofmann-Wellenhof R; Kofler R; Cerroni L; Haas J; Kerl H
    J Invest Dermatol; 1995 Dec; 105(6):797-801. PubMed ID: 7490474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 166.